Inventor · disambiguated record
Nancy Harrison
Also filed as: HARRISON NANCY · HARRISON NANCY E
4 granted patents·14 pending applications·17 citations·filing 2008–2023
75Inventor score
Files withEMERALD HEALTH THERAPEUTICS CANADA INC8METHYLATION SCIENCES INTERNAT SRL3METHYLATION SCIENCES INT SRL2METHYLATION SCIENCES INTERNAT2HARRISON NANCY1
Top patents by PatentIndex Score
18 records- 0182US8580296B2Pharmacokinetics of S-adenosylmethionine formulationsMETHYLATION SCIENCES INTERNAT SRL·Filed 2012·Granted Nov 12, 2013·5 cites·20 claims
- 0281US8329208B2Pharmacokinetics of S-adenosylmethionine formulationsHARRISON NANCY·Filed 2010·Granted Dec 11, 2012·7 cites·48 claims
- 0379US9931356B2Pharmacokinetics of S-adenosylmethionine formulationsMETHYLATION SCIENCES INT SRL·Filed 2016·Granted Apr 3, 2018·2 cites·15 claims
- 0478US8865203B2Pharmacokinetics of S-adenosylmethionine formulationsMETHYLATION SCIENCES INTERNAT SRL·Filed 2012·Granted Oct 21, 2014·3 cites·12 claims
- 0567US2023226015A1Defined dose cannabis puckEMERALD HEALTH THERAPEUTICS CANADA INC·Filed 2023·Application pending·0 cites
- 0662US2022354821A1Defined dose cannabis podEMERALD HEALTH THERAPEUTICS CANADA INC·Filed 2022·Application pending·0 cites
- 0761US2014370108A1Pharmacokinetics of S-Adenosylmethionine FormulationsMETHYLATION SCIENCES INTERNAT SRL·Filed 2014·Application pending·0 cites
- 0860US2019060345A1Pharmacokinetics of s-adenosylmethionine formulationsMETHYLATION SCIENCES INT SRL·Filed 2018·Application pending·0 cites
- 0957US2020405686A1Defined dose cannabis puckEMERALD HEALTH THERAPEUTICS CANADA INC·Filed 2019·Application pending·0 cites
- 1057US2021000789A1Defined dose cannabis podEMERALD HEALTH THERAPEUTICS CANADA INC·Filed 2019·Application pending·0 cites
- 1149US2021236575A1Therapeutic combinations of cannabinoids with curcuminEMERALD HEALTH THERAPEUTICS CANADA INC·Filed 2019·Application pending·0 cites
- 1248US2021338629A1Oral formulations of phenylalanine and cannabinoidsEMERALD HEALTH THERAPEUTICS CANADA INC·Filed 2019·Application pending·0 cites
- 1348US2021196670A1Oral formulations of lavender and cannabinoidsEMERALD HEALTH THERAPEUTICS CANADA INC·Filed 2019·Application pending·0 cites
- 1448US2021205236A1Therapeutic combinations of boswellia extract and cannabinoidsEMERALD HEALTH THERAPEUTICS CANADA INC·Filed 2019·Application pending·0 cites
- 1546US2009088404A1Extended Release Pharmaceutical Formulations of S-AdenosylmethionineMETHYLATION SCIENCES INTERNAT·Filed 2008·Application pending·0 cites
- 1646US2009197824A1Extended Release Pharmaceutical Formulations of S-AdenosylmethionineMETHYLATION SCIENCES INTERNAT·Filed 2008·Application pending·0 cites
- 1741US2013142847A1S-adenosylmethionine formulations with enhanced bioavailabilityMACDONALD I DAVID·Filed 2011·Application pending·0 cites
- 1838US2011027342A1S-adenosylmethionine formulations with enhanced bioavailabilityMSI METHYLATION SCIENCES INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nancy Harrison files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →